155 related articles for article (PubMed ID: 1860150)
21. Comparison of Edmonston-Zagreb and Schwarz strains of measles vaccine given by aerosol or subcutaneous injection.
Khanum S; Uddin N; Garelick H; Mann G; Tomkins A
Lancet; 1987 Jan; 1(8525):150-3. PubMed ID: 2879981
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of measles antibodies before and after vaccination in previously unvaccinated children of the Cordillera Province (Santa Cruz Department, Bolivia).
Guglielmetti P; Bianchi Bandinelli ML; Bartoloni A; Gamboa H; Roselli M; Valensin PE
J Trop Med Hyg; 1994 Aug; 97(4):231-5. PubMed ID: 8064946
[TBL] [Abstract][Full Text] [Related]
23. Trial of high-dose Edmonston-Zagreb measles vaccine in the Gambia: antibody response and side-effects.
Whittle H; Hanlon P; O'Neill K; Hanlon L; Marsh V; Jupp E; Aaby P
Lancet; 1988 Oct; 2(8615):811-4. PubMed ID: 2902264
[TBL] [Abstract][Full Text] [Related]
24. Measles control in Maputo, Mozambique, using a single dose of Schwarz vaccine at age 9 months.
Cutts FT; Monteiro O; Tabard P; Cliff J
Bull World Health Organ; 1994; 72(2):227-31. PubMed ID: 8205642
[TBL] [Abstract][Full Text] [Related]
25. Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial.
Dilraj A; Cutts FT; de Castro JF; Wheeler JG; Brown D; Roth C; Coovadia HM; Bennett JV
Lancet; 2000 Mar; 355(9206):798-803. PubMed ID: 10711928
[TBL] [Abstract][Full Text] [Related]
26. Measles vaccine efficacy in India: a review.
Singh J; Datta KK
J Commun Dis; 1997 Mar; 29(1):47-56. PubMed ID: 9282529
[TBL] [Abstract][Full Text] [Related]
27. [The development and duration of immunity in children vaccinated against measles with the Edmonston-Zagreb vaccine].
Borcić B; Smerdel S; Abu Eldan J; Kolić J; Ferdebar M; Kordić D; Mohacek N
Lijec Vjesn; 1989; 111(4-5):131-4. PubMed ID: 2770398
[TBL] [Abstract][Full Text] [Related]
28. Immunogenicity of standard dose Edmonston-Zagreb measles vaccine in highland Papua New Guinean children from four months of age.
Rogers S; Sanders RC; Alpers MP
J Trop Med Hyg; 1991 Apr; 94(2):88-91. PubMed ID: 2023293
[TBL] [Abstract][Full Text] [Related]
29. Duration of immunity following immunization with live measles vaccine: 15 years of observation in Zhejiang Province, China.
Dai B; Chen ZH; Liu QC; Wu T; Guo CY; Wang XZ; Fang HH; Xiang YZ
Bull World Health Organ; 1991; 69(4):415-23. PubMed ID: 1934235
[TBL] [Abstract][Full Text] [Related]
30. Impact of revaccinating children who initially received measles vaccine before 10 months of age.
Stetler HC; Orenstein WA; Bernier RH; Herrmann KL; Sirotkin B; Hopfensperger D; Schuh R; Albrecht P; Lievens AW; Brunell PA
Pediatrics; 1986 Apr; 77(4):471-6. PubMed ID: 3960615
[TBL] [Abstract][Full Text] [Related]
31. WHO-supported comparative studies of attenuated live measles virus vaccines.
Cockburn WC; Pecenka J; Sundaresan T
Bull World Health Organ; 1966; 34(2):223-31. PubMed ID: 4161187
[TBL] [Abstract][Full Text] [Related]
32. Edmonston-Zagreb strain of measles vaccine: epidemiologic evaluation in Yugoslavia.
Ikić DM
Rev Infect Dis; 1983; 5(3):558-63. PubMed ID: 6879014
[TBL] [Abstract][Full Text] [Related]
33. Measles in infants: a review of studies on incidence, vaccine efficacy and mortality in east Africa.
Burström B; Aaby P; Mutie DM
East Afr Med J; 1995 Mar; 72(3):155-61. PubMed ID: 7796766
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a measles vaccine efficacy during a measles outbreak in Mbare, City of Harare Zimbabwe.
Mahomva AI; Moyo IM; Mbengeranwa LO
Cent Afr J Med; 1997 Sep; 43(9):254-6. PubMed ID: 9509644
[TBL] [Abstract][Full Text] [Related]
35. Induction of cellular and humoral immunity after aerosol or subcutaneous administration of Edmonston-Zagreb measles vaccine as a primary dose to 12-month-old children.
Wong-Chew RM; Islas-Romero R; García-García Mde L; Beeler JA; Audet S; Santos-Preciado JI; Gans H; Lew-Yasukawa L; Maldonado YA; Arvin AM; Valdespino-Gómez JL
J Infect Dis; 2004 Jan; 189(2):254-7. PubMed ID: 14722890
[TBL] [Abstract][Full Text] [Related]
36. Effects of dose and strain of vaccine on success of measles vaccination of infants aged 4-5 months.
Whittle HC; Mann G; Eccles M; O'Neill K; Jupp L; Hanlon P; Hanlon L; Marsh V
Lancet; 1988 Apr; 1(8592):963-6. PubMed ID: 2896828
[TBL] [Abstract][Full Text] [Related]
37. Immunogenicity of measles and rubella vaccines in Oman: a prospective clinical trial.
Kohler KA; Suleiman AJ; Robertson SE; Malankar P; Al-Khusaiby S; Helfand RF; Brown D; Bellini WJ; Sutter RW
J Infect Dis; 2003 May; 187 Suppl 1():S177-85. PubMed ID: 12721911
[TBL] [Abstract][Full Text] [Related]
38. Serological effects of Edmonston-Zagreb, Schwarz, and AIK-C measles vaccine strains given at ages 4-5 or 8-10 months.
Tidjani O; Grunitsky B; Guérin N; Lévy-Bruhl D; Lecam N; Xuereff C; Tatagan K
Lancet; 1989 Dec; 2(8676):1357-60. PubMed ID: 2574304
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants.
Gatchalian S; Yao Y; Zhou B; Zhang L; Yoksan S; Kelly K; Neuzil KM; Yaïch M; Jacobson J
Vaccine; 2008 Apr; 26(18):2234-41. PubMed ID: 18394765
[TBL] [Abstract][Full Text] [Related]
40. Comparative studies of measles vaccines in a controlled trial in the USSR.
Bolotovskij VM; Nefedova LA; Gelikman BG; Zargaryants AT; Zetilova LP; Nastasina KT
Bull World Health Organ; 1966; 34(6):859-64. PubMed ID: 5296534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
